← All Sponsors
SPONSOR

Region Skane

Total Trials
17
Recruiting
17
Phases
Phase 4, Phase 3, Phase 2

Region Skane is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Type 2 Diabetes, Acquired Adult Flatfoot Deformity, Flat Foot, Flexible Flatfoot.

The trial portfolio spans Phase 4, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Region Skane

How many clinical trials has Region Skane sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Region Skane, of which 17 are actively recruiting participants. These trials cover conditions including Type 2 Diabetes, Acquired Adult Flatfoot Deformity, Flat Foot. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Region Skane research focus on?
Region Skane clinical trials span Type 2 Diabetes, Acquired Adult Flatfoot Deformity, Flat Foot, Flexible Flatfoot, Breath-holding Spell, and additional conditions. The research pipeline includes Phase 4, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Region Skane clinical trial?
To participate in a Region Skane trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Region Skane trials with current recruitment status updated daily.

Clinical Trials by Region Skane

NCT07659535
Recruiting

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

Type 2 Diabetes
NCT06211504 Phase 4
Recruiting

Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity

Acquired Adult Flatfoot Deformity
NCT06628271
Recruiting

Breath-holding Spells and Its Management Study

Breath-holding Spell
NCT06486142 Phase 3
Recruiting

EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study

Non-Small Cell Lung Cancer
NCT07245888
Recruiting

ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia

Ventilator Acquired Pneumonia
NCT06370312
Recruiting

Analysis of Articular Biomarkers From Osteoarthritic Thumb Basal Joints

Osteoarthritis Thumb
NCT06099561
Recruiting

Intractable Self-harm-What Support is Effective?

Self-harm
NCT06800781
Recruiting

Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery

Coronary Arterial Disease (CAD)
NCT06922487
Recruiting

Assessment of Tiredness During Awake Resection of Intracerebral Tumors

Brain Tumor Adult
NCT07169747 Phase 2
Recruiting

Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa

Anorexia Nervosa
NCT07134751
Recruiting

Febrile Infants Swedish Study

Febrile Illness Acute
NCT06471972
Recruiting

Biomarkers After Out-of-hospital Cardiac Arrest- a STEPCARE Substudy

Cardiac Arrest
NCT06922500
Recruiting

Processed EEG for Monitoring of Anesthetic Depth in Intracranial Tumor Surgery

Brain Tumor Adult
NCT05698992
Recruiting

Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

Esophageal Cancer
NCT05657899
Recruiting

The With Or Without Olecranon K-wires Trial

Olecranon Fracture
NCT06540222
Recruiting

Sustained Cord Circulation at Emergency Cesarean Section

Asphyxia Neonatorum
NCT05634889
Recruiting

The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.

Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology